KURA ONCOLOGY INC. -

Kura Oncology Announces First Patients Dosed in Phase 2 Registration-Directed Trial of Ziftomenib in NPM1-Mutant Acute Myeloid Leukemia

09 Feb 2023 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology to Participate in SVB Securities Global Biopharma Conference

07 Feb 2023 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology Announces FDA Clearance of IND Application for KO-2806, a Next-Generation Farnesyl Transferase Inhibitor

24 Jan 2023 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology Presents Updated Clinical Data from KOMET-001 Trial of Menin Inhibitor Ziftomenib at American Society of Hematology Annual Meeting

10 Dec 2022 10:30:00 By Nasdaq GlobeNewswire

Kura Oncology to Host Investor Event on December 10, 2022

01 Dec 2022 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology to Participate in Two Upcoming Investor Conferences

22 Nov 2022 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology Announces Four Abstracts Accepted for Presentation at ASH Annual Meeting

03 Nov 2022 09:01:13 By Nasdaq GlobeNewswire

Kura Oncology Reports Third Quarter 2022 Financial Results

03 Nov 2022 07:30:01 By Nasdaq GlobeNewswire

Kura Oncology Announces Financing Transactions with Bristol Myers Squibb and Hercules Capital, Providing Access to up to $150 Million

03 Nov 2022 07:00:01 By Nasdaq GlobeNewswire

Kura Oncology to Participate in Two Upcoming Investor Conferences

02 Nov 2022 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology to Report Third Quarter 2022 Financial Results  

27 Oct 2022 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology Reports Preliminary Proof of Mechanism in Phase 1/2 Clinical Trial of Tipifarnib Plus Alpelisib in Head and Neck Squamous Cell Carcinoma

26 Oct 2022 07:30:01 By Nasdaq GlobeNewswire

Kura Oncology to Participate in H.C. Wainwright Global Investment Conference

01 Sep 2022 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology Reports Second Quarter 2022 Financial Results

03 Aug 2022 16:03:00 By Nasdaq GlobeNewswire

Kura Oncology to Participate in Wedbush PacGrow Healthcare Virtual Conference

02 Aug 2022 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology to Report Second Quarter 2022 Financial Results

27 Jul 2022 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology to Participate in Three Upcoming Investor Conferences

26 May 2022 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology Reports First Quarter 2022 Financial Results

04 May 2022 16:05:01 By Nasdaq GlobeNewswire

Kura Oncology to Report First Quarter 2022 Financial Results

27 Apr 2022 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology Reports Preclinical Data Supporting Use of Tipifarnib to Prevent Emergence of Resistance to Osimertinib in Non-Small Cell Lung Cancer

08 Apr 2022 13:00:00 By Nasdaq GlobeNewswire